Pioglitazone Brown & Burk Uk Ltd 30 Mg Tablets
Out of date information, search another
MICRO LABS LIMITED
Bangalore, INDIA
Approved
By
Sign/
Date
PACKAGE LEAFLET: INFORMATION FORTHEUSER
Pioglitazone 15 mg Tablets Pioglitazone 30 mg Tablets Pioglitazone 45 mg Tablets
(pioglitazone)
1) Product
2) Strength
3) Component
4) No of colours
5) Dimension
6) ArtworkCode
7) Pharma code
8) Font type and Size
9) Technical specification
Reason for change
Contract Giver/ PL holder
Regulatory
Affairs
m
BROWN & BURK
Pioglitazone Tablets Leaflet UK 15/30/45 mg Leaflet 1
150x420 mm
NA
NA
Arial, 9pts NA
Packaging Production
Development Head (Site)
Colours used Black
Colours notforPrintina | Keylines
Revision : 00
Date : 17-10-2014
Head Head
QC (Site) QA (Site)
Read all of this leaflet carefully before you
start taking this medicine because it
contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor, pharmacist or nurse.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If yougetany sideeffects.talktoyourdoctor, pharmacist or nurse.
- This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet
1. What Pioglitazone is and what it is used for
2. What you need to know before you take Pioglitazone
3. HowtotakePioglitazone
4. Possible side effects
5. HowtostorePioglitazone
6. Contents ofthe pack and other information
1. What Pioglitazone is and what it is used for
Pioglitazone tablets contains pioglitazone. It is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus, when metformin is not suitable or has failed to work adequately. This is the diabetes that usually develops in adulthood.
Pioglitazone helps control the level of sugar in your blood when you have type 2 diabetes by helping your body make better use of the insulin it produces. Your doctor will
sthe Pioglitazone is working 3 to 6 months after you start taking it.
Pioglitazone may be used on its own in patients who are unable to take metformin, and where treatment with diet and exercise has failed to control blood sugar or may be added to other therapies (such as metformin, sulphonylurea or insulin) which have failed to provide sufficient control of blood sugar.
If you take Pioglitazone with other medicines for diabetes, it is more likely that your blood sugar could fall below the normal level (hypoglycaemia).
You may also experience a reduction in blood count (anaemia).
Broken bones
A higher number of bone fractures was seen in patients, particularly women taking pioglitazone. Your doctor will take this into account when treating your diabetes.
Children and adolescents
Use in children under 18 years is not recommended.
Other medicines and Pioglitazone
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
You can usually continue to take other medicines whilst you are being treated with Pioglitazone. However, certain medicines are especially likely to affect the amount of sugar in your blood:
- gemfibrozil (used to lower cholesterol)
- rifampicin (used to treat tuberculosis and other infections)
Tell your doctor or pharmacist if you are taking any of these. Your blood sugar will be checked, and your dose of Pioglitazone may need to be changed.
Pioglitazone with food and drink
You may take your tablets with or without food. You should swallow the tablets with a glass of water.
Pregnancy and breast-feeding
Tell your doctor if
- you are, you think you might be or are planning to become pregnant.
- you are breast-feeding or ifyou are planning to breast-feed your baby.
Your doctor will advise you to discontinue this medicine.
Driving and using machines
Pioglitazone will not affect your ability to drive or use machines but take care ifyou experience abnormal vision.
dose as normal. Do not take a double dose to make up for a forgotten tablet.
Ifyou stop taking Pioglitazone
Pioglitazone should be used every day to work properly. If you stop using Pioglitazone, your blood sugar may go up. Talk to your doctor before stopping this treatment.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
- increase in enzymes
Reporting ofside effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
4. Possible side effects
5. HowtostorePioglitazone
2. What you need to know before you take Pioglitazone
Do not take Pioglitazone
- if you are hypersensitive (allergic) to pioglitazone or any ofthe other ingredients of this medicine (listed in section 6).
- if you have heart failure or have had heart failure in the past.
- ifyouhaveliverdisease.
- if you have had diabetic ketoacidosis (a complication of diabetes causing rapid weight loss, nausea orvomiting).
- ifyou have or have ever had bladder cancer.
- ifyou have blood in your urine that your doctor has not checked.
Warnings and precautions
Talk to your doctor, pharmacist or nurse before
taking Pioglitazone
- if you retain water (fluid retention) or have heart failures problems, in particular ifyou are over 75 years old. If you take antiinflammatory medicines which can also cause fluid retention and swelling, you must also tell your doctor.
- if you have a special type of diabetic eye disease called macular oedema (swelling of the back of the eye).
- ifyou have cysts on your ovaries (polycystic ovary syndrome) . There may be an increased possibility of becoming pregnant because you may ovulate again when you take Pioglitazone. If this applies to you, use appropriate contraception to avoid the possibility of an unplanned pregnancy.
- ifyou have a problem with your liver or heart. Before you start taking Pioglitazone, you will have a blood sample taken to check your liver function. This check may be repeated at intervals. Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke, who were treated with Pioglitazone and insulin, experienced the development of heart failure. Inform your doctor as soon as possible ifyou experience signs of heart failure such as unusual shortness of breath or rapid increase in weight or localised swelling (oedema).
Pioglitazone contains
This medicine contains lactose monohydrate. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking Pioglitazone.
3. HowtotakePioglitazone
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist ifyou are not sure.
The recommended dose is one tablet of pioglitazone should be taken once daily. If necessary your doctor may tell you to take a different dose.
If you have the impression that the effect of Pioglitazone is too weak, talk to your doctor.
When Pioglitazone is taken in combination with other medicines used to treat diabetes (such as insulin, chlorpropamide, glibenclamide, gliclazide, tolbutamide) your doctor will tell you whether you need to take a smaller dose of your medicines.
Your doctor will ask you to have blood tests periodically during treatment with Pioglitazone. This is to check that your liver is working normally.
Ifyou are following a diabetic diet, you should continue with this while you are taking Pioglitazone.
Your weight should be checked at regular intervals, if your weight increases, inform your doctor.
If you take more Pioglitazone than you should
If you accidentally take too many tablets, or if someone else or a child takes your medicine, talk to a doctor or pharmacist immediately. Your blood sugar could fall below the normal level and can be increased by taking sugar. It is recommended that you carry some sugar lumps, sweets, biscuits or sugary fruit juice.
Ifyou forget to take Pioglitazone:
Take Pioglitazone daily as prescribed. However ifyou miss a dose, just carry on with the next
Like all medicines, this medicine can cause side effects, although not everybody gets them.
In particular, patients have experienced the following serious side effects:
Heart failure has been experienced commonly (1 to 10 users in 100) in patients taking Pioglitazone in combination with insulin. Symptoms are unusual shortness of breath or rapid increase in weight or localised swelling (oedema). If you experience any of these, especially ifyou are over the age of 65, seek medical advice straight away.
Bladder cancer has been experienced uncommonly (1 to 10 users in 1000) in patients taking Pioglitazone. Signs and symptoms include blood in your urine, pain when urinating or a sudden need to urinate. Ifyou experience any of these, talk to your doctor as soon as possible.
Localised swelling (oedema) has also been experienced very commonly in patients taking Pioglitazone in combination with insulin. Ifyou experience this side effect, talk to your doctor as soon as possible.
Broken bones have been reported commonly (1 to 10 users in 100) in women patients taking Pioglitazone. Ifyou experience this side effect, talk to your doctor as soon as possible.
Blurred vision due to swelling (or fluid) at the back ofthe eye (frequency not known) has also been reported in patients taking Pioglitazone. If you experience this symptom for the first time, talk to your doctor as soon as possible. Also if you already have blurred vision and the symptom gets worse, talk to your doctor as soon as possible.
Allergic reactions have been reported (frequency not known) in patients taking Pioglitazone. If you have a serious allergic reaction, including hives and swelling of the face, lips, tongue, or throat that may cause difficulty in breathing or swallowing stop taking this medicine and talk to your doctor as soon as possible.
The other side effects that have been experienced by some patients taking Pioglitazone are:
common (affects 1 to 10 users in 100)
- weight gain
- respiratory infection
- numbness
- abnormal vision
uncommon (affects 1 to 10 users in 1,000)
- inflammation ofthe sinuses (sinusitis)
- difficulty sleeping (insomnia)
not known (frequency cannot be estimated from the available data)
- increase in liver enzymes
- allergic reactions
The other side effects that have been experienced by some patients when Pioglitazone is taken with other antidiabetic medicines are:
very common (affects more than 1 user in 10)
- decreased blood sugar (hypoglycaemia)
common (affects 1 to 10 users in 100)
- headache
- dizziness
- flatulence
- joint pain
- impotence
- small reduction in red blood cell count
- back pain
- shortness of breath
uncommon (affects 1 to 10 users in 1,000)
- spinning sensation (vertigo)
- sweating
- tiredness
- sugarinurine, proteins in urine
- increased appetite
Keep this medicine out ofthe sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blister pack after the word EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage precautions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
WhatPioglitazone contains
- The active substance is pioglitazone. Each tablet contains either 15 mg, 30 mg or 45 mg of pioglitazone (as hydrochloride).
- The other ingredients are lactose monohydrate, hydroxypropylcellulose, carmellose calcium and magnesium stearate.
What Pioglitazone looks like and contents of the pack
Piogiilazone 15 mg Tabiots are white to off white, circular, flat, beveled edged uncoated tablets with '15'engraved on one face and plain on other.
Piogtilazone 30 mg Tabiats are white to off white, circular, flat, beveled edged uncoated tablets with 'B 30’ engraved on one face and plain on other.
Piogtilazone 45 mg Tabiats are white to off white, circular, flat, beveled edged uncoated tablets with 'B 45’ engraved on one face and plain on other.
The tablets are supplied in blister packs of 10, 14, 28,30, 50, 56, 84, 90, 98,112 or 196 tablets. They may also be supplied in tablet containers of 500 or1000 tablets.
Not all the pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Brown & Burk UK Ltd
5 Marryat Close
Hounslow West
Middlesex
TW4 5DQ
UK.
This medicinal product is authorised in the Member States of the EEA under the following names:
SE : Pioglitazone Brown 15mg/30mg/45mg tabletter
UK : Pioglitazone Brown and Burk UK Ltd 15mg/30mg/45mg Tablets DE : Pioglitazon-Micro Labs
15mg/30mg/45mg Tabletten
This leaflet was last approved in October 2014
420mm
11 ■ ■ 1111 ■ ■ 11 ■ ■ 1111 ■ ■